广发纳斯达克生物科技人民币(001092)

动态评分: 5.23分

投资组合

报告日期 名称 比例
2021-12-31 NovoCure Ltd 0.36%
2021-12-31 Pacific Biosciences of California Inc 0.36%
2021-12-31 Kodiak Sciences Inc 0.36%
2021-12-31 Intra-Cellular Therapies Inc 0.35%
2021-12-31 再鼎医药 0.34%
2021-12-31 Ionis Pharmaceuticals Inc 0.34%
2021-12-31 Twist Bioscience Corp 0.32%
2021-12-31 Adaptive Biotechnologies Corp 0.32%
2021-12-31 Aurinia Pharmaceuticals Inc 0.31%
2021-12-31 Apellis Pharmaceuticals Inc 0.31%
2021-12-31 CureVac NV 0.29%
2021-12-31 Arvinas Holding Co LLC 0.29%
2021-12-31 Karuna Therapeutics Inc 0.28%
2021-12-31 阿卡迪亚 0.27%
2021-12-31 Cytokinetics Inc 0.27%
2021-12-31 阿尔凯默斯 0.27%
2021-12-31 Relay Therapeutics Inc 0.26%
2021-12-31 Zentalis Pharmaceuticals Inc 0.26%
2021-12-31 Maravai LifeSciences Holdings Inc-A 0.25%
2021-12-31 Insmed Inc 0.24%

投资模拟

公告&资料